Organization · Venture Capital
Mianus Capital
Mianus Capital is a life-sciences venture capital firm based in Wisconsin, specializing in early-stage biotechnology investments with a focus on ophthalmology. The firm leverages its partnership with MERIT CRO to enhance its investment strategy.
Overview
What Mianus Capital does
What Mianus Capital is
Mianus Capital is a life-sciences venture capital firm based in Wisconsin, specializing in early-stage biotechnology investments with a focus on ophthalmology. The firm leverages its partnership with MERIT CRO to enhance its investment strategy.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Mianus Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Mianus Capital as a funder
Investment thesis
Mianus Capital focuses on early-stage biotechnology innovation, particularly in ophthalmology, leveraging its partnership with MERIT CRO to enhance clinical development and accelerate transformative therapies.
Focus narrative
Mianus Capital invests in early-stage biotech companies, specifically targeting Seed and Pre-A funding rounds. The firm emphasizes a diversified portfolio across various therapeutic areas, leveraging insights from its strategic partner, MERIT CRO, to support clinical development. The organization aims to combine Western biotech innovation with China's clinical ecosystem to accelerate the development of transformative therapies.
Value beyond capital
Mianus Capital provides its portfolio companies with access to clinical trial expertise and operational support through its partnership with MERIT CRO, enhancing their ability to navigate the drug development process effectively.
Focus and fit
- Stages
- Seed · Series A · Series A+
- Regions
- Global
Availability
- Currently deploying
- Not published
Common questions
What to know about Mianus Capital
Upseed classifies Mianus Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.